Our CEO Grace Colón participated in the panel "Cardiovascular and Nephrology: a Renewed Interest" at Biotech Showcase 2021 on January 11, 2021. More information below: Drug development in nephrology and cardiovascular specialties have had a revival of venture investments in recent years, after facing headwinds regarding...
Grace Colón joins the First Rounders Podcast (aired on 1/2/21). The conversation covers growing up in San Juan; her love musical theater; and how grad school at MIT guided her toward a career in entrepreneurship. https://play.acast.com/s/naturebiotechnologypodcast/gracecolon...
Grace Colón and Jeff Ho join a FIRESIDE chat with Umer Raffat & Michael DiFiore on Dec 2, 2020. Grace and Jeff share an overview of how InCarda Therapeutics, Inc will be changing the lives of patients with AFIB. Grace Colón and Jeff Ho join a...
On Friday, November 13 at 9:00am CT/10:00am ET, Dr. Harry Crijns, Clinical Electrophysiologist from Maastricht University Medical Center in the Netherlands, will present data from the open-label, dose-escalation Part A portion of InCarda’s multinational INSTANT Phase 2 clinical trial of InRhythm™ (flecainide for inhalation) in...
InCarda Therapeutics and our President & CEO Grace Colón were featured in a recent post on Endpoints News. The post highlights InCarda's Raise of $30 Million Through First Close of Series C Equity Financing. More information below: “This is especially exciting at a time when more...
InCarda Therapeutics and our President & CEO Grace Colón were featured in a recent post on Endpoints News. The post highlights InCarda's Raise of $30 Million Through First Close of Series C Equity Financing. More information below: “What we're doing is a completely new way of...
Achieving Corporate Diversity and Inclusion Goals through investment and Policy Choices Grace Colón participated in an educational panel discussion regarding diversity and inclusion during BIO Investor Forum Digital 2020. A recent Nature Biotechnology article notes that less than 1% of the nearly 200 senior-level positions on investment teams...
Grace Colón presented Transforming Cardiovascular Treatment with Pulmonary Delivery at the Oppenheimer Private Life Sciences Company Call Series on 8/18/2020 with Host: Leland Gershell, Oppenheimer & Co. Inc. Grace presented how this is a major unmet market need Significant market (>30M patients globally; >$50B US healthcare...
Biotech2050 podcast which aired 6/18/2020 featuring our President and CEO Grace Colon! She shares how her passion for #engineering and #biotech lead to our breakthrough approach to treat #AFib. Hear our story here: https://bit.ly/37wTDN9 #WomenInSTEM #cardiovascular #clinicaltrials #medicaldevice #biotech #startup...
Our CEO Grace Colón moderated the "Digital Health in Respiratory Care – The Next Frontier" panel at Bio Digital Week 2020. More information below: While most of the attention in the use of digital health for chronic care management has gone to players in the diabetes,...